Skip to content
Search

Latest Stories

Sandwell Council launches public survey to review local pharmacy services

Sandwell Council launches public survey to review local pharmacy services
getyyimages

The feedback will help determine whether there are enough pharmacies in Sandwell offering the necessary services for residents

Sandwell Council is inviting residents to participate in a survey to share their opinions on local pharmacy services.

The survey is part of the Pharmaceutical Needs Assessment (PNA), which has been conducted every three years since 2013.


The feedback collected will assist in updating the report that evaluates the community's pharmacy needs, the location and offerings of local pharmacies, and identifies any gaps in services. The PNA also provides recommendations for improving pharmacy services.

Councillor Jackie Taylor, Sandwell Council’s cabinet member for adult services, health and wellbeing, emphasised that the survey helps ensure that “there are enough pharmacies in Sandwell offering the services people need.”

“Residents may not know what provision is available from pharmacies that they can get instead of waiting for a GP appointment and we would like to understand how many residents are aware of this service and use it or, if not, why not?”

“Pharmacies are important for keeping our community healthy. I encourage everyone in Sandwell to take the survey and share their views about local pharmacies and the services they provide,” she said.

Residents have until Friday, 7 February 2025, to complete the survey and have their say.

Since 1 April 2013, the Health and Social Care Act 2012 has required every Health and Wellbeing Board in England to publish and maintain an updated statement of pharmaceutical service needs.

The Pharmaceutical Needs Assessment (PNA) helps guide the commissioning of pharmaceutical services based on local priorities and is used by NHS England in making decisions regarding the opening of new pharmacies.

An analysis by the National Pharmacy Association (NPA), published in September 2024, revealed that nearly nine in ten council areas across England have lost vital pharmacies in the past two years.

The body warned that many rural areas risk becoming “pharmacy deserts” if the current closure rates continue.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less